244 related articles for article (PubMed ID: 20405011)
1. The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.
McCabe CJ; Goldie SJ; Fisman DN
PLoS One; 2010 Apr; 5(4):e10154. PubMed ID: 20405011
[TBL] [Abstract][Full Text] [Related]
2. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
3. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
Katz IT; Leister E; Kacanek D; Hughes MD; Bardeguez A; Livingston E; Stek A; Shapiro DE; Tuomala R
Ann Intern Med; 2015 Jan; 162(2):90-9. PubMed ID: 25599347
[TBL] [Abstract][Full Text] [Related]
5. Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
Tweya H; Keiser O; Haas AD; Tenthani L; Phiri S; Egger M; Estill J
AIDS; 2016 Mar; 30(6):953-62. PubMed ID: 26691682
[TBL] [Abstract][Full Text] [Related]
6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
9. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
10. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.
Boer K; Nellen JF; Patel D; Timmermans S; Tempelman C; Wibaut M; Sluman MA; van der Ende ME; Godfried MH
BJOG; 2007 Feb; 114(2):148-55. PubMed ID: 17305888
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
Avram CM; Greiner KS; Tilden E; Caughey AB
Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
[TBL] [Abstract][Full Text] [Related]
12. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
Frederick T; Homans J; Spencer L; Kramer F; Stek A; Operskalski E; Kovacs A
Clin Infect Dis; 2012 Sep; 55(6):877-84. PubMed ID: 22675157
[TBL] [Abstract][Full Text] [Related]
13. Correlation between viral loads performed at 34-36 weeks and in the immediate postpartum period in HIV-infected pregnant women using HAART.
Gouvea MI; Teixeira ML; João EC; Souza CV; Quintana MB; Cruz ML; Read JS
Am J Obstet Gynecol; 2015 May; 212(5):683-4. PubMed ID: 25617733
[No Abstract] [Full Text] [Related]
14. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.
Katz IT; Shapiro R; Li D; Govindarajulu U; Thompson B; Watts DH; Hughes MD; Tuomala R
J Acquir Immune Defic Syndr; 2010 May; 54(1):27-34. PubMed ID: 20065861
[TBL] [Abstract][Full Text] [Related]
16. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
17. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
19. Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda.
Binagwaho A; Pegurri E; Drobac PC; Mugwaneza P; Stulac SN; Wagner CM; Karema C; Tsague L
PLoS One; 2013; 8(2):e54180. PubMed ID: 23437040
[TBL] [Abstract][Full Text] [Related]
20. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
Rodrigues A; Faucher P; Batallan A; Allal L; Legac S; Matheron S; Madelenat P
Gynecol Obstet Fertil; 2006 Apr; 34(4):304-11. PubMed ID: 16574463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
